Synthon s.r.o. (responsible for batch release)

Ukraine

All drugs from this manufacturer

  • BENDAMUSVISTA

    The drug is used for the therapy of chronic lymphocytic leukemia, indolent non-Hodgkin lymphomas, as well as multiple myeloma (in combination with prednisone for patients of a certain age and condition).

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 25 mg

    ATC: L01AA09

  • The drug is used for the therapy of chronic lymphocytic leukemia (first-line), indolent non-Hodgkin lymphomas (as monotherapy in case of disease progression), and multiple myeloma (in combination with prednisone for patients of a certain age and condition).

    Dosage form: powder for preparation of concentrate for infusion solution

    Active substance Dosage
    bendamustine 100 mg

    ATC: L01AA09